Want to buy for someone else? You can purchase a token at check out.
Overview
This course provides the healthcare team with an overview of multidrug-resistant (MDR) UTIs.Goals and Learning Outcomes
This course will discuss a brief review of the diagnosis of UTIs and a detailed review of available oral antimicrobials and treatment strategies for multidrug-resistant (MDR) UTIs.
The goal of this course is to educate the healthcare team in all types of healthcare settings on MDR UTIs.
- Recall general UTI symptoms, diagnosis, classification, and appropriate urine sample collection methods.
- Identify oral antibiotics that are active against extended-spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae (EPE), AmpC ß-lactamase-producing bacteria, and vancomycin-resistant enterococci (VRE).
- Determine a patient-specific antibiotic regimen that limits adverse effects.
Course Details
Course Originally Released on : 3/1/2025
REL-ACU-0-TRMDRUTI
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791


Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
